| Gene symbol | FLT3 | Synonyms | CD135, FLK-2, FLK2, STK1 | Type of gene | protein-coding |
| Chromosome | 13 | Map location | 13q12.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | fms related receptor tyrosine kinase 3 | ||||
| GTO ID | GTC3103 |
| Trial ID | NCT05445011 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | FLT3 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | TAA05 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Anti-FLT3 CAR-T Cell (TAA05 Cell Injection) in the Treatment of Relapsed / Refractory Acute Myeloid Leukemia |
| Year | 2022 |
| Country | China |
| Company sponsor | Wuhan Union Hospital, China |
| Other ID(s) | Anti-FLT3 CAR-T Cell |
| Cohort 1 | |||||||||||
|
|||||||||||